Literature DB >> 23652853

Hypoxia promotes radioresistance of CD133-positive Hep-2 human laryngeal squamous carcinoma cells in vitro.

Maoxin Wang1, Xiaoming Li, Yongtao Qu, Ou Xu, Qingjia Sun.   

Abstract

Hypoxia promotes the radioresistance of laryngeal carcinomas and CD133 is one of the markers expressed by tumor-initiating, human laryngeal carcinoma cells. In order to investigate whether CD133-positive Hep-2 cells exhibit a radioresistant phenotype and to determine whether hypoxia promotes this phenotype, we performed a series of experiments. Hep-2 cells, and Hep-2 cells stably expressing hypoxia-inducible factor (HIF)-targeted small interfering RNA (siRNA) were cultured under hypoxic and normoxic conditions and were treated with varying doses of γ-rays (0, 5, 10, 15 and 20 Gy). MTT and cell cycle assays were subsequently performed. Using fluorescence-activated cell sorting (FACS), CD133-positive Hep-2 cells and CD133-positive HIF-siRNA Hep-2 cells were isolated. These cells were grown as spheres under hypoxic and normoxic conditions for MTT and soft agar colony formation assays. The expression levels of DNA-dependent protein kinase catalytic subunit (DNA-PKcs), survivin, p53 and ataxia-telangiectasia mutated (ATM) were also assayed using flow cytometry. The data showed that the growth of Hep-2 cells exposed to hypoxic conditions and treated with 10 Gy radiation (group A) was less compared to that of groups B-D (P<0.05). In addition, more cells in group A were arrested in the G1 phase of the cell cycle compared to groups B-D (P<0.05). The percentage of CD133+ cells detected after radiation increased and was the highest for group A (P<0.05). In sphere formation assays, significantly more CD133+ cells grew in spheres than CD133- cells (P<0.001). Moreover, sphere formation was the highest for CD133+ Hep-2 cells grown under hypoxic conditions and exposed to irradiation (group E) (P<0.05). Lastly, expression of DNA-PKcs and survivin for group E was the highest (P<0.05), while ATM and p53 levels remained largely unchanged (P>0.05). In conclusion, CD133-positive Hep-2 cells exhibited a radioresistant phenotype that was enhanced with hypoxia. Furthermore, an increase in DNA-PK activity was associated with this enhancement.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23652853     DOI: 10.3892/ijo.2013.1929

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

1.  Efficacy of radiation exposure in laryngeal squamous cell carcinoma is mediated by the LAMP3/LAMC2/tenascin-C pathway.

Authors:  Hao Wu; Juanjuan Li; Jianqiu Chen; Yong Yin; Peng Da; Qingwen Chen; Zhenxin Zhang; Jinxing Wang; Guohua Wang; Xiaoxia Qiu
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-07

2.  LAMP3 and TP53 overexpression predicts poor outcome in laryngeal squamous cell carcinoma.

Authors:  Xiaoxia Qiu; Yiwen You; Jianfei Huang; Xudong Wang; Huijun Zhu; Zhiwei Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 3.  Cancer stem cells in laryngeal cancer: what we know.

Authors:  A Greco; Maria Ida Rizzo; A De Virgilio; A Gallo; M Fusconi; G Pagliuca; S Martellucci; R Turchetta; M De Vincentiis
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-19       Impact factor: 2.503

Review 4.  Cancer stem cells and signaling pathways in radioresistance.

Authors:  Lei Chang; Peter Graham; Jingli Hao; Jie Ni; Junli Deng; Joseph Bucci; David Malouf; David Gillatt; Yong Li
Journal:  Oncotarget       Date:  2016-03-08

5.  In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.

Authors:  Li-Fang Shen; Xin Zhao; Shui-Hong Zhou; Zhong-Jie Lu; Kui Zhao; Jun Fan; Min-Li Zhou
Journal:  Oncotarget       Date:  2017-05-23

6.  Inhibition of GLUT-1 expression and the PI3K/Akt pathway to enhance the chemosensitivity of laryngeal carcinoma cells in vitro.

Authors:  Tao Jiang; Min-Li Zhou; Jun Fan
Journal:  Onco Targets Ther       Date:  2018-11-06       Impact factor: 4.147

Review 7.  Targeting carbonic anhydrase IX activity and expression.

Authors:  Brian P Mahon; Melissa A Pinard; Robert McKenna
Journal:  Molecules       Date:  2015-01-30       Impact factor: 4.411

Review 8.  Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinoma.

Authors:  Jiang-Tao Zhong; Shui-Hong Zhou
Journal:  Oncotarget       Date:  2017-02-21

9.  Dihydroartemisinin Prevents Distant Metastasis of Laryngeal Carcinoma by Inactivating STAT3 in Cancer Stem Cells.

Authors:  Weiyi Wang; Yajing Sun; Xiaoming Li; Xinli Shi; Zhen Li; Xiuying Lu
Journal:  Med Sci Monit       Date:  2020-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.